Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma
Xin Zhao, Fei Guo, Zhonghu Li, et al.
Oncology Reports (2016) Vol. 36, Iss. 1, pp. 419-427
Open Access | Times Cited: 20

Showing 20 citing articles:

New B7 Family Checkpoints in Human Cancers
Ling Ni, Chen Dong
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 7, pp. 1203-1211
Open Access | Times Cited: 210
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
Krista Kinneer, Philipp Wortmann, Zachary A. Cooper, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1086-1101
Open Access | Times Cited: 37
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1026-1026
Open Access | Times Cited: 30
B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis
Zhimeng Ye, Zhuojun Zheng, Xiaodong Li, et al.
Cellular Physiology and Biochemistry (2016) Vol. 39, Iss. 4, pp. 1568-1580
Open Access | Times Cited: 56
Prognostic impact of CD8+ T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma
Yoh Asahi, Kanako C. Hatanaka, Yutaka Hatanaka, et al.
Surgery Today (2020) Vol. 50, Iss. 8, pp. 931-940
Closed Access | Times Cited: 43
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Hengsong Cao, Tian Huang, Mingrui Dai, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5369-5390
Open Access | Times Cited: 27
SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models
Elizabeth Gray, Michelle Ulrich, Angela Epp, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007572-e007572
Open Access | Times Cited: 13
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
Sarah B. Gitto, Margaret Whicker, Gareth Davies, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 8, pp. 1567-1581
Open Access | Times Cited: 10
B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
Lingwei Shen, Yun Qian, Weigen Wu, et al.
Human Pathology (2017) Vol. 66, pp. 79-85
Closed Access | Times Cited: 32
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
Guoying Zhou, Patrick P.C. Boor, Marco J. Bruno, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 10-23
Open Access | Times Cited: 20
Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis
Miriam Dawidowicz, Agnieszka Kula, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5045-5045
Open Access | Times Cited: 2
B7H4 Role in Solid Cancers: A Review of the Literature
Miriam Dawidowicz, Anna Kot, Sylwia Mielcarska, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2519-2519
Open Access | Times Cited: 2
Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases
Yun Qian, Yiwen Sang, Frederick X.C. Wang, et al.
Oncotarget (2016) Vol. 7, Iss. 44, pp. 72242-72249
Open Access | Times Cited: 20
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
Lu Cao, Prashanth Prithviraj, Ritu Shrestha, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2191-2191
Open Access | Times Cited: 17
Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
Hong Wu, Yulong Wei, Jian Mei, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 39-51
Open Access | Times Cited: 14
Prognostic biomarkers for cholangiocarcinoma and their clinical implications
Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 6, pp. 579-592
Closed Access | Times Cited: 14
Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities
Xiaoxin Ren, Yixian Li, Christopher Nishimura, et al.
Genes & Diseases (2021) Vol. 9, Iss. 5, pp. 1181-1193
Open Access | Times Cited: 10
Comprehensive molecular profiling of the B7 family in gastrointestinal cancer
Qijie Zhao, Fuyan Hu, Zhangang Xiao, et al.
Cell Proliferation (2018) Vol. 51, Iss. 5
Open Access | Times Cited: 11
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer
Shaun Alexander, Umair Aleem, Timothy W. Jacobs, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3345-3345
Open Access
Page 1

Scroll to top